RA0113

antibody from Oursmab

Targeting: CD40 Bp50, p50, TNFRSF5

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0113

Provider

Oursmab

Product name

Dalnicastobart (Biosimilar Reference Antibody) (CD40)

Antibody type

Monoclonal

Description

Dalnicastobart is a humanized, agonistic monoclonal antibody designed as an immunotherapy targeting the B-cell surface antigen CD40. It functions by stimulating the CD40 signaling pathway, leading to potent activation of antigen-presenting cells, enhancement of T-cell-mediated immune responses, and direct anti-tumor effects against CD40-expressing malignancies. This immunostimulatory and antineoplastic agent is being investigated for the treatment of various cancers, either as a monotherapy or in combination with other immunotherapeutic or chemotherapeutic regimens.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Dalnicastobart (Biosimilar Reference Antibody) (CD40)-RA0113-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.